These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6926537)

  • 1. Does mixing pancreatic enzyme microspheres (Pancrease) with food damage the enteric coating?
    Sackman JW; Smith KE; Graham DY
    J Pediatr Gastroenterol Nutr; 1982; 1(3):333-5. PubMed ID: 6926537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.
    Brugge WR; Goldberg HJ; Burke CA; Depping BJ
    Dig Dis Sci; 1988 Oct; 33(10):1226-32. PubMed ID: 3168695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study.
    Petersen W; Heilmann C; Garne S
    Acta Paediatr Scand; 1987 Jan; 76(1):66-9. PubMed ID: 3551493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of product formulation on in vitro activity of pancreatic enzymes.
    Dressman JB; Shtohryn LV; Diokno D
    Am J Hosp Pharm; 1985 Nov; 42(11):2502-6. PubMed ID: 4073069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
    Gan KH; Geus WP; Bakker W; Lamers CB; Heijerman HG
    Aliment Pharmacol Ther; 1996 Oct; 10(5):771-5. PubMed ID: 8899086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancrease gastroresistance: in vitro evaluation of pH-determined dissolution.
    Lenaerts C; Beraud N; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S18-21. PubMed ID: 3404358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two enteric coated microspheres in cystic fibrosis.
    Williams J; MacDonald A; Weller PH; Fields J; Pandov H
    Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
    Vyas H; Matthew DJ; Milla PJ
    Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding.
    Wells KA; Losin WG
    Clin Ther; 2008 Jul; 30(7):1300-8. PubMed ID: 18691989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine.
    Stead RJ; Skypala I; Hodson ME
    Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.